20664593

Source:http://linkedlifedata.com/resource/pubmed/id/20664593

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0005515, umls-concept:C0020792, umls-concept:C0079218, umls-concept:C0681890, umls-concept:C0871261, umls-concept:C0939537, umls-concept:C1704632, umls-concept:C1706817, umls-concept:C2911692
pubmed:issue	4
pubmed:dateCreated	2010-8-10
pubmed:abstractText	Imatinib induces responses and disease stabilisations in non-resectable patients with aggressive fibromatosis (AF). The precise target of imatinib in AF and predictive factors for response to treatment are unknown.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/20664593-10738207, http://linkedlifedata.com/resource/pubmed/commentcorrection/20664593-12436445, http://linkedlifedata.com/resource/pubmed/commentcorrection/20664593-12562642, http://linkedlifedata.com/resource/pubmed/commentcorrection/20664593-15286804, http://linkedlifedata.com/resource/pubmed/commentcorrection/20664593-16505440, http://linkedlifedata.com/resource/pubmed/commentcorrection/20664593-16703880, http://linkedlifedata.com/resource/pubmed/commentcorrection/20664593-17077361, http://linkedlifedata.com/resource/pubmed/commentcorrection/20664593-17695408, http://linkedlifedata.com/resource/pubmed/commentcorrection/20664593-18413817, http://linkedlifedata.com/resource/pubmed/commentcorrection/20664593-19568815, http://linkedlifedata.com/resource/pubmed/commentcorrection/20664593-20339585
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0370635
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Piperazines, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-kit, http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological, http://linkedlifedata.com/resource/pubmed/chemical/imatinib
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	1532-1827
pubmed:author	pubmed-author:BertucciFF, pubmed-author:BlayJ YJY, pubmed-author:BringuierP PPP, pubmed-author:BuiBB, pubmed-author:ChevreauCC, pubmed-author:CupissolDD, pubmed-author:DufresneAA, pubmed-author:GoncalvesAA, pubmed-author:JimenezMM, pubmed-author:Le CesneAA, pubmed-author:PenevDD, pubmed-author:PerolDD, pubmed-author:Ray-CoquardII, pubmed-author:Tubiana-HulinMM
pubmed:issnType	Electronic
pubmed:day	10
pubmed:volume	103
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	482-5
pubmed:dateRevised	2011-8-25
pubmed:meshHeading	pubmed-meshheading:20664593-Adult, pubmed-meshheading:20664593-Aged, pubmed-meshheading:20664593-Female, pubmed-meshheading:20664593-Fibromatosis, Aggressive, pubmed-meshheading:20664593-Humans, pubmed-meshheading:20664593-Immunohistochemistry, pubmed-meshheading:20664593-Male, pubmed-meshheading:20664593-Middle Aged, pubmed-meshheading:20664593-Piperazines, pubmed-meshheading:20664593-Prognosis, pubmed-meshheading:20664593-Proto-Oncogene Proteins c-kit, pubmed-meshheading:20664593-Pyrimidines, pubmed-meshheading:20664593-Treatment Outcome, pubmed-meshheading:20664593-Tumor Markers, Biological, pubmed-meshheading:20664593-Young Adult
pubmed:year	2010
pubmed:articleTitle	Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis.
pubmed:affiliation	Department of Medical Oncology and Department of Pathological Anatomy, Hospital Edouard Herrriot, Lyon, France.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase II